Drug Design and Discovery
Artificial Intelligence-Based Drug Design and Discovery
... The drug discovery process from hit-to-lead has been a challenging task that requires simultaneously optimizing numerous factors from maximizing compound activity, efficacy to minimizing toxicity and ...
18
ROLE OF COMPUTER AIDED DRUG DESIGN IN DRUG DEVELOPMENT AND DRUG DISCOVERY
... of drug development and drug discovery is very challenging, expensive and time ...aided drug design (CADD) also known as in silico screening has become a powerful technique because of ...
11
Current progress in Structure-Based Rational Drug Design marks a new mindset in drug discovery.
... preclinical drug discovery with structure-based drug design (SBDD) making a comeback while high-throughput screening (HTS) methods have continued to generate disappointing ...allows ...
15
“COMPUTER-AIDED DRUG DESIGN - A NEW APPROACH IN DRUG DESIGN AND DISCOVERY” Satyajit Dutta*, India.
... Two distinct approaches are possible in the area of computer-aided drug design. If the molecular structure of the target macromolecule is known the methods are obvious and direct and have achieved a high ...
6
Meta-QSAR: a large-scale application of meta-learning to drug design and discovery
... 6 Conclusions QSAR learning is one of the most important and established applications of machine learn- ing. We demonstrate that meta-learning can be leveraged to build QSAR models which, on average, could improve ...
28
Machine Learning in Drug Discovery and Drug Design
... the drug development process, 50% of the failures[133] in late development stages are due to an unfavorable ADMET profile (Absorption, Distribution, Metabolism, Excretion & ...the drug molecules are ...
176
Data Warehouse Design for Pharmaceutical Drug Discovery Research
... consumption of substrate is measured over time. If a test compound is present that has inhibitory activity against the enzyme, a decrease in turnover of substrate is observed. This decrease is commonly expressed as the ...
7
iDrug: a web-accessible and interactive drug discovery and design platform
... molecular design programs and enormous data collections to meet the systematic oper- ations of users to achieve the best results ...structure-based drug design such as molecular docking and de novo ...
8
A perspective on multi target drug discovery and design for complex diseases
... to drug design in recent years, building on the molecular structure deter- minations of previous decades (a process still ongoing for membrane proteins such as ...to design novel struc- tures, and to ...
14
Pyrazoles in Drug Discovery
... During the last few years, more and more pyrazole-containing drugs have gained regulatory approval, most conspicuously in the field of kinase inhibitors. Nearly all kinase inhibitors are competitive inhibitors, occupying ...
18
Furopyridines in Drug Discovery
... As in the case of phenylpyridine switch, furopyridines have some advantages over the parent benzofurans. The nitrogen atom may serve as a hydrogen bond acceptor and result in additional proteinligand interactions. ...
13
Novel Approach for Drug Discovery
... as drug design and drug discovery, where this information is utilized to identify, design and optimize new drugs of pharmacological ...interest. Drug search and discovery ...
19
optimizing the "Drug-Like" Properties of Leads in Drug Discovery
... the discovery research division within a ...of drug design. The result was that scientists in discovery research were advancing what they thought were high quality drug candidates into ...
9
Modern drug discovery technologies: opportunities and challenges in lead discovery
... Keywords: Drug discovery, ligand-based drug design, high throughput screening, virtual screening, lead ...the drug discovery process, chemical libraries varying widely in size ...
11
Recent Trends in In-silico Drug Discovery
... BASED DRUG DESIGNING: Structure based drug design [4] is based on three dimensional structural information which is obtained by modern biophysical techniques like NMR and X-ray ...based drug ...
23
Synthetic biology for pharmaceutical drug discovery
... validate drug target or disease models as well as merging con- straints from both DD and drug ...biosynthetic drug design” 34 approach is somehow the other side of the de novo rational-based ...
18
Rational design of phenothiazinium derivatives and photoantimicrobial drug discovery
... potential drug candidates is an essential step in the design/development ...a design viewpoint this is often a redundant step given that differences in solvent, oxygenation and – importantly – ...
27
Drug Discovery and Design Center, Key Laboratory of Receptor Research, State Key
... Catalyzes the NADPH-dependent reduction of a wide variety of carbonyl- containing compounds to their corresponding alcohols with a broad range of catalytic efficienci[r] ...
15
Interferon, viruses and drug discovery
... To design a cell-based assay for use in HTS, there are a number of criteria that need to be considered. Firstly, the target needs to be identified. In a cell-based phenotypic assay, this does not need to be a ...
221
Bioinformatics in translational drug discovery
... potential drug (ap- proximately 30%), unexpected toxicities (>20%) as well as the inherent commercial concerns (>20%) of being able to successfully position a new drug within a competitive market ...the ...
13